NASDAQ · Biotechnology

VKTX (VKTX) Stock

$33.43 -1.27% NASDAQ: VKTX Healthcare

Valuation

MetricValue
Price$33.43
Market Cap$3.88B
P/E Ratio-6.90
P/B Ratio5.63
P/S Ratio0.00
EPS (TTM)$-3.19
52-Week High$43.15
52-Week Low$22.96
Dividend Yield—

Financials & Margins

MetricValue
ROE-70.04%
ROA-42.53%
ROCE-61.50%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio9.30

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-56.0M$-70.0M$-101.0M$-151.0M$-393.0M
Net Profit$-55.0M$-69.0M$-86.0M$-110.0M$-360.0M
EPS$-0.70$-0.88$-0.91$-1.01$-3.19
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$211.0M$169.0M$368.0M$908.0M$716.0M
Total Liabilities$9.0M$23.0M$20.0M$28.0M$77.0M
Cash$26.0M$37.0M$56.0M$27.0M$166.0M
Borrowings$0$2.0M$1.0M$1.0M$0

Latest News

Here Is Why Viking Therapeutics (VKTX) is Amongst The Most Affordable Biotech Stocks to Buy Insider Monkey · Jul 15, 2026 As AI Rewrites Drug Discovery, This Bio-Native AI Company Just Joined the Russell 3000E, and Reports Earnings July 22 CNW Group · Jul 15, 2026 Viking Therapeutics, Inc. (VKTX) Stock Falls Amid Market Uptick: What Investors Need to Know Zacks · Jul 10, 2026 Novo Nordisk (NYSE:NVO) Updates Wegovy Label In Singapore With STEP UP Data Simply Wall St. · Jul 9, 2026 3 High Growth GLP-1 Biotech Winners to Buy in July 24/7 Wall St. · Jul 9, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-48.0M$-48.0M$-73.0M$-88.0M$-279.0M
Investing Cash Flow$38.0M$55.0M$-179.0M$-553.0M$341.0M
Financing Cash Flow$-1.0M$6.0M$2.0M$15.0M$74.0M
Net Cash Flow$-3.0M$10.0M$19.0M$-29.0M$139.0M
Free Cash Flow$-48.0M$-48.0M$-73.0M$-88.0M$-279.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.03
EV / EBITDA—
FCF Yield-7.67%
Quick Ratio5.67
Interest Coverage—
Return 1Y15.89%
Return 3Y142.19%
Return 5Y544.71%

Ownership

Insiders Held2.79%
Institutions Held64.47%
Institutions Float Held66.32%
Institutional HolderSharesReport Date
Blackrock Inc.6,880,2902026-03-31
FMR, LLC6,024,7532026-03-31
Vanguard Capital Management LLC5,012,5022026-03-31
Vanguard Portfolio Management LLC4,464,2982026-03-31
Two Sigma Investments, LP4,432,1422026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPGAscentage Pharma Group International $20.18 +4.89% -9.87 $1.88B 0.00%
ACAD $29.21 +2.67% 8.94 $5.00B 0.00%
AKROAkero Therapeutics, Inc. $54.65 +0.00% -19.87 $4.50B 0.00%
CRNX $83.81 -0.09% -8.57 $8.87B 0.00%
IMVT $39.24 +1.91% -11.09 $8.06B 0.00%

About VKTX

VKTX stock trades at $33.43 with a market capitalization of $3.88B. The stock is valued at a price-to-earnings (P/E) ratio of -6.90, price-to-book of 5.63, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $22.96 and $43.15, and currently trades 22.5% below its 52-week high.

On profitability, VKTX generates a return on equity (ROE) of -70.04%, return on capital employed of -61.50%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides